We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$15.6M
Cap. Flow
+$5.46M
Cap. Flow %
2.37%
Top 10 Hldgs %
6.97%
Holding
827
New
263
Increased
114
Reduced
126
Closed
324

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.45M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.42M
3
G icon
Genpact
G
+$1.42M
4
CHRW icon
C.H. Robinson
CHRW
+$1.34M
5
OGE icon
OGE Energy
OGE
+$1.31M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.44M
2
MDLZ icon
Mondelez International
MDLZ
+$1.42M
3
AVT icon
Avnet
AVT
+$1.21M
4
MRVL icon
Marvell Technology
MRVL
+$1.04M
5
XYZ
Block Inc
XYZ
+$987K

Sector Composition

Rank Sector Weight
1 Technology 21.25%
2 Consumer Discretionary 15.35%
3 Healthcare 13.63%
4 Industrials 12.99%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONEW icon
701
OneWater Marine
ONEW
$201M
– –
-17,761
Closed -$287K
OSK icon
702
Oshkosh
OSK
$9.59B
– –
-4,290
Closed -$404K
OSPN icon
703
OneSpan
OSPN
$618M
– –
-11,690
Closed -$178K
PACK icon
704
Ranpak Holdings
PACK
$473M
– –
-11,002
Closed -$59.6K
PAG icon
705
Penske Automotive Group
PAG
$14.2B
– –
-2,375
Closed -$342K
PARAA
706
DELISTED
Paramount Global Class A
PARAA
– –
-10,630
Closed -$242K
PAYX icon
707
Paychex
PAYX
$42.7B
– –
-3,750
Closed -$579K
PB icon
708
Prosperity Bancshares
PB
$8.89B
– –
-4,690
Closed -$335K
PBI icon
709
Pitney Bowes
PBI
$2.39B
– –
-19,110
Closed -$173K
PBYI icon
710
Puma Biotechnology
PBYI
$454M
– –
-12,224
Closed -$36.2K
PCG icon
711
PG&E
PCG
$38.5B
– –
-31,883
Closed -$548K
PEB icon
712
Pebblebrook Hotel Trust
PEB
$2.05B
– –
-22,277
Closed -$226K
PEGA icon
713
Pegasystems
PEGA
$5.38B
– –
-12,156
Closed -$423K
PEP icon
714
PepsiCo
PEP
$190B
– –
-2,434
Closed -$365K
PFE icon
715
Pfizer
PFE
$153B
– –
-15,501
Closed -$393K
PGC icon
716
Peapack-Gladstone Financial
PGC
$812M
– –
-7,477
Closed -$212K
PGR icon
717
Progressive
PGR
$125B
– –
-714
Closed -$202K
PH icon
718
Parker-Hannifin
PH
$135B
– –
-1,192
Closed -$725K
PHAT icon
719
Phathom Pharmaceuticals
PHAT
$692M
– –
-26,307
Closed -$165K
PHM icon
720
Pultegroup
PHM
$25.3B
– –
-2,122
Closed -$218K
PLD icon
721
Prologis
PLD
$133B
– –
-1,824
Closed -$204K
PLTK icon
722
Playtika
PLTK
$1.12B
– –
-10,327
Closed -$53.4K
PNFP icon
723
Pinnacle Financial Partners Inc
PNFP
$15.8B
– –
-3,158
Closed -$335K
PPL
724
PPL Corp
PPL
$26.7B
– –
-12,076
Closed -$436K
PRA
725
DELISTED
ProAssurance
PRA
– –
-10,511
Closed -$245K
27 28
29
30 31

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Sherbrooke Park Advisers held 827 positions worth $230M, up 7.3% from $215M the previous quarter. Its ten largest holdings account for 7% of the portfolio.

Sherbrooke Park Advisers's Q2 2025 filing shows 263 new, 114 increased, 126 reduced and 324 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M. The largest sale was Merck, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Sherbrooke Park Advisers's largest Q2 2025 buy was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M.
  • Sherbrooke Park Advisers added most to CMS Energy in Q2 2025, an estimated $1.14M increase.
  • Sherbrooke Park Advisers's biggest Q2 2025 reduction was MasTec, cutting an estimated $947K.
  • Sherbrooke Park Advisers fully exited Merck in Q2 2025, selling an estimated $1.44M.
  • Sherbrooke Park Advisers's ten largest holdings make up 7% of its $230M portfolio in Q2 2025.
  • Sherbrooke Park Advisers opened 263 new positions and closed 324 in Q2 2025.
  • Sherbrooke Park Advisers's portfolio value rose 7.3% quarter-over-quarter to $230M.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.